Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation routing

Prioritisation routing

Decision

Decision

Showing 1 to 10 of 24

TitlePrioritisation routingDecisionDecision date
Sentinel Node Biopsy approved for pathological staging of clinically T1-T2 N0 oral cancerNone selectedNot selected
Technologies to improve the detection of endometrial cancerNone selectedAwaiting decision
Subcutaneous pembrolizumab with platinum-based chemotherapy for untreated metastatic non-small-cell lung cancer [TSID12213]None selectedNot selected
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency (MA review of TA779) [ID6326]None selectedAwaiting decision
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121]None selectedAwaiting decision
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]None selectedNot selected
Subcutaneous amivantamab for treating advanced non-small-cell lung cancer with EGFR mutations [TSID12011]None selectedNot selected
MRI-guided laser interstitial thermal therapy for early prostate cancerNone selectedNot selected
Percutaneous cryotherapy (PCT) for the therapy of primary lung cancer or metastatic lung cancerNone selectedNot selected
Use of a glue or sealant to achieve lung volume reduction in emphysema and lung cancerNone selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All